Overview
Current Appointments & Affiliations
Professor of Medicine
·
2021 - Present
Medicine, Hematologic Malignancies and Cellular Therapy,
Medicine
Member of the Duke Cancer Institute
·
2013 - Present
Duke Cancer Institute,
Institutes and Centers
Recent Publications
A 79-Year-Old Female Patient With Altered Mental Status and Anemia.
Journal Article Arthritis Care Res (Hoboken) · April 2022 Full text Link to item CitePhase II Study of Single-Agent and Combination Everolimus and Panobinostat in Relapsed or Refractory Diffuse Large B-Cell Lymphoma.
Journal Article Cancer Invest · November 2021 Novel therapeutics are needed for patients with relapsed or refractory diffuse large B-cell lymphoma (R/R DLBCL). Everolimus is an mTOR pathway inhibitor with synergistic anti-tumor activity when combined with histone deacetylase inhibitors, such as panobi ... Full text Link to item CiteA+AVD versus eBEACOPP in advanced-stage Hodgkin lymphoma.
Journal Article Lancet Haematol · June 2021 Full text Link to item CiteEducation, Training & Certifications
Georgetown University ·
1975
M.D.